178 related articles for article (PubMed ID: 22464338)
1. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
J Psychiatr Res; 2012 Jun; 46(6):757-61. PubMed ID: 22464338
[TBL] [Abstract][Full Text] [Related]
2. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
Matsuda Y; Sato S; Iwata K; Furukawa S; Hatsuse N; Watanabe Y; Anzai N; Kishimoto T; Ikebuchi E
Psychiatry Clin Neurosci; 2014 Jun; 68(6):425-31. PubMed ID: 24506576
[TBL] [Abstract][Full Text] [Related]
3. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Yasui-Furukori N; Kaneda A; Sugawara N; Tomita T; Kaneko S
J Psychopharmacol; 2012 Jun; 26(6):806-12. PubMed ID: 21616975
[TBL] [Abstract][Full Text] [Related]
5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
6. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
Suzuki H; Gen K; Inoue Y
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):161-8. PubMed ID: 21047544
[TBL] [Abstract][Full Text] [Related]
7. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
8. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
De Risio A; Pancheri A; Simonetti G; Giannarelli D; Stefanutto L; Gentile B
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1112-6. PubMed ID: 21447367
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.
Guo X; Zhai J; Wei Q; Twamley EW; Jin H; Fang M; Hu M; Zhao J;
Neurosci Lett; 2011 Oct; 503(2):141-6. PubMed ID: 21888948
[TBL] [Abstract][Full Text] [Related]
10. Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):138-42. PubMed ID: 22136174
[TBL] [Abstract][Full Text] [Related]
11. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
[TBL] [Abstract][Full Text] [Related]
12. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
Miura I; Takeuchi S; Katsumi A; Kanno K; Watanabe K; Mashiko H; Niwa S
Hum Psychopharmacol; 2012 Sep; 27(5):517-20. PubMed ID: 22927115
[TBL] [Abstract][Full Text] [Related]
13. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
[TBL] [Abstract][Full Text] [Related]
14. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee JH; Lee YH; Yang SJ; Yoon JS
Clin Neuropharmacol; 2009; 32(5):243-9. PubMed ID: 19620849
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.
Elie D; Poirier M; Chianetta J; Durand M; Grégoire C; Grignon S
J Psychopharmacol; 2010 Jul; 24(7):1037-44. PubMed ID: 19164494
[TBL] [Abstract][Full Text] [Related]
18. Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.
Kishi T; Moriwaki M; Kitajima T; Kawashima K; Okochi T; Fukuo Y; Furukawa O; Naitoh H; Fujita K; Iwata N
Psychopharmacology (Berl); 2010 Apr; 209(2):185-90. PubMed ID: 20177883
[TBL] [Abstract][Full Text] [Related]
19. Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia.
Kontis D; Theochari E; Kleisas S; Kalogerakou S; Andreopoulou A; Psaras R; Makris Y; Karouzos C; Tsaltas E
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1333-41. PubMed ID: 20691745
[TBL] [Abstract][Full Text] [Related]
20. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
